44 related articles for article (PubMed ID: 38442460)
1. Advances in human papillomavirus detection and molecular understanding in head and neck cancers: Implications for clinical management.
Tran NH; Sais D; Tran N
J Med Virol; 2024 Jun; 96(6):e29746. PubMed ID: 38884391
[TBL] [Abstract][Full Text] [Related]
2. Sinonasal squamous cell carcinoma in the United States: Temporal and geographic patterns associated with HPV testing and positivity.
Costantino A; Haughey B; Zhu J; Mekhail T; Kandula S; Alamoudi U; Biskup M; Magnuson JS
Oral Oncol; 2024 Jul; 154():106855. PubMed ID: 38788337
[TBL] [Abstract][Full Text] [Related]
3. Incidence and risk factors of HPV-related and HPV-unrelated Head and Neck Squamous Cell Carcinoma in HIV-infected individuals.
Beachler DC; Abraham AG; Silverberg MJ; Jing Y; Fakhry C; Gill MJ; Dubrow R; Kitahata MM; Klein MB; Burchell AN; Korthuis PT; Moore RD; D'Souza G;
Oral Oncol; 2014 Dec; 50(12):1169-76. PubMed ID: 25301563
[TBL] [Abstract][Full Text] [Related]
4. The impact of COVID-19 and vaccination status on outcomes in veterans with head and neck squamous cell carcinoma.
Johns JD; Choe EJ; Chisolm PF; Pothast MJ; Randolph JR; Chou J; Maxwell JH
Head Neck; 2024 Jul; 46(7):1698-1705. PubMed ID: 38433326
[TBL] [Abstract][Full Text] [Related]
5. Double trouble: Synchronous and metachronous primaries confound ctHPVDNA monitoring.
Naegele S; Efthymiou V; Hirayama S; Zhao BY; Das D; Chan AW; Richmon JD; Iafrate AJ; Faden DL
Head Neck; 2023 Jun; 45(6):E25-E30. PubMed ID: 37080924
[TBL] [Abstract][Full Text] [Related]
6. Intra-tumor genetic heterogeneity and mortality in head and neck cancer: analysis of data from the Cancer Genome Atlas.
Mroz EA; Tward AD; Hammon RJ; Ren Y; Rocco JW
PLoS Med; 2015 Feb; 12(2):e1001786. PubMed ID: 25668320
[TBL] [Abstract][Full Text] [Related]
7. Survival Impact of Increasing Time to Treatment Initiation for Patients With Head and Neck Cancer in the United States.
Murphy CT; Galloway TJ; Handorf EA; Egleston BL; Wang LS; Mehra R; Flieder DB; Ridge JA
J Clin Oncol; 2016 Jan; 34(2):169-78. PubMed ID: 26628469
[TBL] [Abstract][Full Text] [Related]
8. Prevalence of human papillomavirus in head and neck cancer patients in India: a systematic review and meta-analysis.
Satapathy P; Khatib MN; Gaidhane S; Zahiruddin QS; Serhan HA; Sharma RK; Sharma D; Arora M; Rustagi S; Na A; Alsayyah A; Al-Hajeili M; Al-Subaie MF; Alfaresi M; Alissa M; Rabaan AA
BMC Infect Dis; 2024 May; 24(1):516. PubMed ID: 38783184
[TBL] [Abstract][Full Text] [Related]
9. Epidemiologic Trends in Human Papillomavirus-Associated Sinonasal Squamous Cell Carcinoma.
Amanian A; Ishii M; Fakhry C; London NR
JAMA Otolaryngol Head Neck Surg; 2024 Jun; ():. PubMed ID: 38842800
[TBL] [Abstract][Full Text] [Related]
10. The changing therapeutic landscape of head and neck cancer.
Cramer JD; Burtness B; Le QT; Ferris RL
Nat Rev Clin Oncol; 2019 Nov; 16(11):669-683. PubMed ID: 31189965
[TBL] [Abstract][Full Text] [Related]
11. Plasma circulating tumor DNA testing in the management of HPV-associated sinonasal and nasopharyngeal tumors.
Im E; Kuan EC; Adappa ND; Patel A; Chapurin N
Int Forum Allergy Rhinol; 2024 Jun; 14(6):1011-1015. PubMed ID: 38716783
[No Abstract] [Full Text] [Related]
12. Impact of human papillomavirus status on survival in patients with oral cancer.
Tangthongkum M; Phisalmongkhon S; Leelasawatsuk P; Supanimitjaroenporn P; Kirtsreesakul V; Tantipisit J
Laryngoscope Investig Otolaryngol; 2024 Jun; 9(3):e1294. PubMed ID: 38867852
[TBL] [Abstract][Full Text] [Related]
13. Human Papillomavirus Infection of the Oropharyngeal and Laryngeal Squamous Papilloma: Disparities in Prevalence and Characteristics.
Kwak J; Ahn D; Kim MS
Diagnostics (Basel); 2024 May; 14(11):. PubMed ID: 38893689
[TBL] [Abstract][Full Text] [Related]
14. Potentially functional variants of CHMP4A and PANX1 in the pyroptosis-related pathway predict survival of patients with non-oropharyngeal head and neck squamous cell carcinoma.
Tang X; Wang H; Liu H; Li G; Sturgis EM; Shete S; Wei Q
Mol Carcinog; 2024 Jun; ():. PubMed ID: 38860607
[TBL] [Abstract][Full Text] [Related]
15. Rare case of poorly differentiated squamous cell cancer of HPV etiology in a nasal polyp presenting as chronic sinusitis.
Bhat SP; Wyll A; Kwon H
Proc (Bayl Univ Med Cent); 2024; 37(4):666-669. PubMed ID: 38910823
[TBL] [Abstract][Full Text] [Related]
16. Identification and Surveillance of Unusual Primary Site Using Human Papillomavirus-Specific Cell-Free Tumor DNA.
Whitehead RA; Papagiannopoulos P; Joshi N; Bhayani MK
Otolaryngol Head Neck Surg; 2024 Jun; ():. PubMed ID: 38881384
[No Abstract] [Full Text] [Related]
17. Commentary on "Impact of tumor subsite on survival outcomes in oral squamous cell carcinoma: A retrospective cohort study from 2000 to 2019".
Khan M
Oral Oncol; 2024 Jun; 155():106905. PubMed ID: 38885554
[No Abstract] [Full Text] [Related]
18. Evaluating human papillomavirus testing, prevalence, and association with prognosis in head and neck squamous cell carcinoma by subsite: A national cancer database study.
Barlow J; Gilja S; Ferrandino RM; Berger MH; Posner MR; Bakst RL; Khan MN; Teng MS; Genden EM; Chai RL; Roof SA
Am J Otolaryngol; 2024; 45(3):104243. PubMed ID: 38442460
[TBL] [Abstract][Full Text] [Related]
19. Association of Human Papillomavirus Status at Head and Neck Carcinoma Subsites With Overall Survival.
Li H; Torabi SJ; Yarbrough WG; Mehra S; Osborn HA; Judson B
JAMA Otolaryngol Head Neck Surg; 2018 Jun; 144(6):519-525. PubMed ID: 29801040
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
